Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.

Taphoorn MJB, Dirven L, Kanner AA, Lavy-Shahaf G, Weinberg U, Taillibert S, Toms SA, Honnorat J, Chen TC, Sroubek J, David C, Idbaih A, Easaw JC, Kim CY, Bruna J, Hottinger AF, Kew Y, Roth P, Desai R, Villano JL, Kirson ED, Ram Z, Stupp R.

JAMA Oncol. 2018 Apr 1;4(4):495-504. doi: 10.1001/jamaoncol.2017.5082.

2.

Vaccine hesitancy among parents in a multi-ethnic country, Malaysia.

Mohd Azizi FS, Kew Y, Moy FM.

Vaccine. 2017 May 19;35(22):2955-2961. doi: 10.1016/j.vaccine.2017.04.010. Epub 2017 Apr 20.

PMID:
28434687
3.

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial.

Ahmed N, Brawley V, Hegde M, Bielamowicz K, Kalra M, Landi D, Robertson C, Gray TL, Diouf O, Wakefield A, Ghazi A, Gerken C, Yi Z, Ashoori A, Wu MF, Liu H, Rooney C, Dotti G, Gee A, Su J, Kew Y, Baskin D, Zhang YJ, New P, Grilley B, Stojakovic M, Hicks J, Powell SZ, Brenner MK, Heslop HE, Grossman R, Wels WS, Gottschalk S.

JAMA Oncol. 2017 Aug 1;3(8):1094-1101. doi: 10.1001/jamaoncol.2017.0184.

PMID:
28426845
4.

Prevalence and associations of neuropathic pain in a cohort of multi-ethnic Asian low back pain patients.

Kew Y, Tan CY, Ng CJ, Thang SS, Tan LH, Khoo YK, Lim JN, Ng JH, Chan CY, Kwan MK, Goh KJ.

Rheumatol Int. 2017 Apr;37(4):633-639. doi: 10.1007/s00296-016-3633-x. Epub 2016 Dec 24.

PMID:
28013358
5.

Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.

Thomas JG, Rao G, Kew Y, Prabhu SS.

Neurosurg Focus. 2016 Oct;41(4):E12.

PMID:
27690657
6.

Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial.

Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, Taylor LP, Lieberman F, Silvani A, Fink KL, Barnett GH, Zhu JJ, Henson JW, Engelhard HH, Chen TC, Tran DD, Sroubek J, Tran ND, Hottinger AF, Landolfi J, Desai R, Caroli M, Kew Y, Honnorat J, Idbaih A, Kirson ED, Weinberg U, Palti Y, Hegi ME, Ram Z.

JAMA. 2015 Dec 15;314(23):2535-43. doi: 10.1001/jama.2015.16669.

PMID:
26670971
7.
8.

Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).

Mrugala MM, Engelhard HH, Dinh Tran D, Kew Y, Cavaliere R, Villano JL, Annenelie Bota D, Rudnick J, Love Sumrall A, Zhu JJ, Butowski N.

Semin Oncol. 2014 Oct;41 Suppl 6:S4-S13. doi: 10.1053/j.seminoncol.2014.09.010. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e33-43.

9.

Overexpression and constitutive nuclear localization of cohesin protease Separase protein correlates with high incidence of relapse and reduced overall survival in glioblastoma multiforme.

Mukherjee M, Byrd T, Brawley VS, Bielamowicz K, Li XN, Merchant F, Maitra S, Sumazin P, Fuller G, Kew Y, Sun D, Powell SZ, Ahmed N, Zhang N, Pati D.

J Neurooncol. 2014 Aug;119(1):27-35. doi: 10.1007/s11060-014-1458-6. Epub 2014 May 4. Erratum in: J Neurooncol. 2014 Aug;119(1):37. Ahmed, Nabil M [Corrected to Ahmed, Nabil].

10.

Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.

Hegde M, Corder A, Chow KK, Mukherjee M, Ashoori A, Kew Y, Zhang YJ, Baskin DS, Merchant FA, Brawley VS, Byrd TT, Krebs S, Wu MF, Liu H, Heslop HE, Gottschalk S, Yvon E, Ahmed N.

Mol Ther. 2013 Nov;21(11):2087-101. doi: 10.1038/mt.2013.185. Epub 2013 Aug 13. Erratum in: Mol Ther. 2014 May;22(5):1063. Gottachalk, Stephen [corrected to Gottschalk, Stephen].

11.

T cells redirected to EphA2 for the immunotherapy of glioblastoma.

Chow KK, Naik S, Kakarla S, Brawley VS, Shaffer DR, Yi Z, Rainusso N, Wu MF, Liu H, Kew Y, Grossman RG, Powell S, Lee D, Ahmed N, Gottschalk S.

Mol Ther. 2013 Mar;21(3):629-37. doi: 10.1038/mt.2012.210. Epub 2012 Oct 16.

12.

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.

Ghazi A, Ashoori A, Hanley PJ, Brawley VS, Shaffer DR, Kew Y, Powell SZ, Grossman R, Grada Z, Scheurer ME, Hegde M, Leen AM, Bollard CM, Rooney CM, Heslop HE, Gottschalk S, Ahmed N.

J Immunother. 2012 Feb-Mar;35(2):159-68. doi: 10.1097/CJI.0b013e318247642f.

13.

Desmoplastic non-infantile ganglioglioma in late adulthood.

Rangel-Castilla L, Kew Y, Powell S, Zhang YJ.

J Neurooncol. 2011 Jul;103(3):733-7. doi: 10.1007/s11060-010-0410-7. Epub 2010 Sep 21.

PMID:
20857318
14.

Dissemination of prostate adenocarcinoma to the skull base mimicking giant trigeminal schwannoma: anatomic relevance of the extradural neural axis component.

Gasco J, Kew Y, Livingston A, Rose J, Zhang YJ.

Skull Base. 2009 Nov;19(6):425-30. doi: 10.1055/s-0029-1224774.

15.

HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.

Ahmed N, Salsman VS, Kew Y, Shaffer D, Powell S, Zhang YJ, Grossman RG, Heslop HE, Gottschalk S.

Clin Cancer Res. 2010 Jan 15;16(2):474-85. doi: 10.1158/1078-0432.CCR-09-1322. Epub 2010 Jan 12.

16.

Advances in gene therapy and immunotherapy for brain tumors.

Kew Y, Levin VA.

Curr Opin Neurol. 2003 Dec;16(6):665-70. Review.

PMID:
14624074
17.
18.
22.

Expression of human glucocerebrosidase in long-term reconstituted mice following retroviral-mediated gene transfer into hematopoietic stem cells.

Correll PH, Kew Y, Perry LK, Brady RO, Fink JK, Karlsson S.

Hum Gene Ther. 1990 Fall;1(3):277-87.

PMID:
2081194

Supplemental Content

Support Center